AAN 2013: more on the safety of oral cladribine

"The following is the safety profile of oral cladribine in the ORACLE or CIS study that was presented at the AAN." "The mos...

Endothelin-2 another new factor that promotes remyelination

Epub : Yuen et al. Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain. 2013...

Vocational rehabilitation helps keep you employed. Or does it?

#MSBlog : Vocational rehab and employment status. Chicken or Egg? Talk about stating the obvious. Epub : Chiu et al. State vocational rehabi...

Guest Post: Dr. Robert Fox on CCSVI

Today we have a guest post from Doctor Robert Fox from the Cleveland Clinic in the USA. Dr. Robert Fox, is Staff Neurologist and Medical Dir...

Guest post: Peter Stys's train crash analogy

"Peter Stys has agreed to allow us to reproduce his train crash analogy that he uses to propose an alternate interpretation of the path...

Drugs take time to Work

Yokoseki A, Saji E, Arakawa M, Hokari M, Ishiguro T, Yanagimura F, Ishihara T, Okamoto K, Nishizawa M, Kawachi I. Relapse of multiple sclero...

Cladribine CIS study

"I was asked last night what was the highlight of the AAN 2013. Without a doubt the Cladribine CIS, or ORACLE, study. As you can see fr...